Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Carcinoma (Phase 2)

Carcinoma in Situ (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 1)

Carcinoma, Transitional Cell (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Congenital Abnormalities (Phase 1)

Diabetic Foot (Phase 2)

Foot Ulcer (Phase 2)

Genital Neoplasms, Male (Phase 2)

HIV Infections (Phase 1)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Kidney Neoplasms (Phase 1)

Lung Neoplasms (Phase 2)

Lymphopenia (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Second Primary (Phase 2)

Neutropenia (Phase 2)

Ovarian Neoplasms (Phase 2)

Preleukemia (Phase 1)

Prostatic Neoplasms (Phase 2)

Psoriasis (Phase 1)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Syndrome (Phase 1)

Thrombocytopenia (Phase 2)

Ulcer (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urogenital Neoplasms (Phase 2)

Urologic Neoplasms (Phase 2)